Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 18 clinical trials
Clinical Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

To evaluate the efficacy of KHK7791 by comparing changes in serum phosphorus levels from baseline values between hemodialysis patients with hyperphosphatemia receiving repeated administration of

  • 0 views
  • 07 May, 2021
  • 1 location
Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis

To evaluate the efficacy of KHK7791 by comparing changes in serum phosphorus levels from baseline values between peritoneal dialysis patients with hyperphosphatemia receiving repeated

  • 0 views
  • 23 Mar, 2021
  • 1 location
Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

To investigate the safety of repeated administration of KHK7791 for 52 weeks while switching from a phosphate-binding agent to KHK7791 in Hemodialysis patients with hyperphosphatemia.

  • 0 views
  • 11 May, 2021
  • 1 location
Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

To evaluate the efficacy of KHK7791 in combination with phosphate binders by comparing changes in serum phosphorus levels between hemodialysis patients with hyperphosphatemia receiving repeated

  • 0 views
  • 05 May, 2021
  • 1 location
A Phase 2 Study to Evaluate the Safety and Efficacy of VS-505 to Treat Hyperphosphatemia in Hemodialysis Patients

given orally with meal for 6 weeks to treat hyperphosphatemia in chronic kidney disease subjects receiving maintenance hemodialysis.

  • 0 views
  • 30 May, 2021
  • 3 locations
To Evaluate the Patient Tolerance Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder

The aim of the study is: To evaluate the tolerance of lanthanum polystyrene sulfonate powder in patients with end-stage renal disease (ESRD-HD) hyperphosphatemia with multiple doses and

fasting
chronic kidney disease
lanthanum carbonate 500 mg
renal disease
lanthanum carbonate
  • 0 views
  • 04 Aug, 2021
  • 1 location
Safety and Efficacy of Pemigatinib in Patients With High-risk Urothelial Cancer After Radical Surgery

The purpose of this clinical trial is to demonstrate the benefit of Pemigatinib, a drug that has indicated promising effects for relapse free survival in molecularly-selected, high-risk patients with urothelial carcinoma who have received radical surgery. Patients will receive Pemigatinib at a once-daily dose on a continuous schedule, continued until …

  • 0 views
  • 23 Feb, 2021
  • 3 locations
Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

During end-stage kidney disease, clinical guidelines suggest reducing elevated phosphate levels in the blood. However, the effect of lowering blood phosphate levels on important patient-centred outcomes has never been tested. This trial will evaluate whether compared to high levels, lowering blood phosphate levels would reduce death or major events due …

renal disease
blood phosphate
dialysis
diabetes
heart disease
  • 91 views
  • 15 Jul, 2021
  • 55 locations
Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia

This is a randomized, open-label study to evaluate different methods of initiating tenapanor therapy in CKD patients on dialysis with hyperphosphatemia, when they are either phosphate binder

  • 0 views
  • 04 Feb, 2021
  • 1 location
Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis Patients

Prospective pilot study to determine if changing the phosphate binder to sucroferric oxyhydroxide for for 6 months improves disordered mineral metabolism and nutrition status in peritoneal dialysis patients.

serum phosphate
sucroferric oxyhydroxide chewable tablet
velphoro
dialysis
phosphate binder
  • 0 views
  • 26 Jan, 2021
  • 1 location